1000s Evacuated As Massive Wall Of Water Surges Through Ukraine After Major Dam 'Blown Up'
Journalists Are Asking Ukrainian Soldiers To Hide Their Nazi Patches, NYT Admits
Comey: Imagine A "Retribution Presidency" Where The President Ordered The...
El Salvador Unleashes "Volcano Energy" With 241 Megawatt Planned Bitcoin Mining Operation
Newly Developed Humanoid Robot Warns About AI Creating "Oppressive Society"
Scientists develop mega-thin solar cells that could be shockingly easy to produce:
High-tech pen paints healing gel right into wounds
EG4 18K after 1 Megawatt Hour! Is it worth the $$$?
Terminator-style Synthetic Covering for Robots Mimics Human Skin and Heals Itself
The Death of 2FA (2 Factor Authentication)? + Q&A
High-speed orbital data link drags space communications out of the '60s
WORLD'S FIRST 3D PRINTED CLAY HOUSES
Smaller, cheaper, safer: The next generation of nuclear power, explained
At 70 years of age, John Lay was diagnosed with ALS, the incurable progressive motor neuron disease known as Lou Gehrig's disease—which Stephen Hawking had.
It was a cruel blow for a man in his golden years when things like playing with grandchildren, passing knowledge onto younger generations, and picking up new hobbies tend to be the features of one's week to week, but Lay took it in his stride.
"I was disappointed to have a diagnosis like that, but I was also very grateful to be 70 years old and to have lived a wonderful, rewarding life and to have so many great people in my life," Lay said. "This was something that we would learn to deal with and to learn from it and to contribute something if we could."
In order to contribute, Lay was enrolled in a phase 2a trial from Coya Therapies at Houston Methodist Hospital, who are currently designing a novel treatment for ALS that involves seeing if T-regulatory cells, or "Tregs," could potentially be re-trained to halt the attack on one's own cells which characterize autoimmune diseases like ALS, and also neurodegenerative diseases like Alzheimer's.